4//SEC Filing
Foster Jonathan P. 4
Accession 0001437749-25-035184
CIK 0001659617other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:08 PM ET
Size
7.8 KB
Accession
0001437749-25-035184
Insider Transaction Report
Form 4
Foster Jonathan P.
EVP & CFO
Transactions
- Award
Performance Based Restricted Stock Units
2025-11-12+400,000→ 2,017,695 totalExp: 2035-11-12→ Common Stock (400,000 underlying) - Award
Stock option (right to buy)
2025-11-12+600,000→ 1,617,695 totalExercise: $0.49Exp: 2035-11-12→ Common Stock (600,000 underlying)
Footnotes (4)
- [F1]The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
- [F2]Issued in connection with the reporting person's employment with the Company.
- [F3]Each restricted stock unit represents a contingent right to receive one shares of Company common stock.
- [F4]On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest.
Documents
Issuer
Moleculin Biotech, Inc.
CIK 0001659617
Entity typeother
Related Parties
1- filerCIK 0001545414
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:08 PM ET
- Size
- 7.8 KB